STOCK TITAN

GoodRx (NASDAQ: GDRX) investors re-elect board and ratify KPMG, back pay

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

GoodRx Holdings, Inc. reported the results of its annual stockholder meeting held on June 16, 2026. Class A stockholders had one vote per share and Class B stockholders had ten votes per share as of the April 20, 2026 record date.

A total of 89,932,951 Class A shares and 233,964,187 Class B shares were represented, accounting for approximately 99.4% of the combined voting power. Stockholders elected Wendy Barnes, Ronald E. Bruehlman and Gregory Mondre as Class III directors.

They also ratified the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, and approved, on an advisory and non-binding basis, the compensation of the company’s named executive officers.

Positive

  • None.

Negative

  • None.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Class A shares represented 89,932,951 shares At annual meeting as of April 20, 2026 record date
Class B shares represented 233,964,187 shares At annual meeting as of April 20, 2026 record date
Combined voting power represented approximately 99.4% Combined Class A and Class B at annual meeting
Votes for Wendy Barnes 2,379,952,868 votes Election as Class III director
Votes for KPMG ratification 2,429,055,999 votes Auditor for fiscal year ending December 31, 2026
Votes for executive pay 2,363,913,370 votes Advisory approval of named executive officer compensation
Class B common stock financial
"holders of the Company’s Class B common stock were entitled to ten votes per share"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
broker non-votes financial
"Wendy Barnes | 2,379,952,868 | 10,078,860 | 39,543,093"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
advisory (non-binding) basis financial
"Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers"
record date financial
"as of the close of business on April 20, 2026 (the “Record Date”)"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001809519FALSE2701 Olympic BoulevardSanta MonicaCalifornia00018095192026-06-162026-06-16
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________________________
FORM 8-K
________________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 16, 2026
________________________________________
GoodRx Holdings, Inc.
(Exact Name of Registrant as Specified in its Charter)
________________________________________
Delaware
001-39549
47-5104396
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
2701 Olympic Boulevard
Santa Monica, California
90404
(Address of Principal Executive
Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: (855) 268-2822
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.0001 par value per
share
GDRX
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act
of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act.
Item 5.07. Submission of Matters to a Vote of Security Holders
On June 16, 2026, GoodRx Holdings, Inc. (the “Company”) held its Annual Meeting of Stockholders. Holders of the
Company’s Class A common stock were entitled to one vote per share held as of the close of business on April 20, 2026 (the
“Record Date”) and holders of the Company’s Class B common stock were entitled to ten votes per share held as of the
Record Date. A total of 89,932,951 shares of the Company’s Class A common stock and 233,964,187 shares of the
Company’s Class B common stock were present in person or represented by proxy at the meeting, representing
approximately 99.4% of the combined voting power of the Company’s Class A and Class B common stock as of the Record
Date. The following are the final voting results for the proposals considered and voted upon at the meeting, each of which
were described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April
29, 2026.
Item 1 — Election of three Class III directors for a term of office expiring on the date of the Annual Meeting of
Stockholders to be held in 2029 and until their respective successors have been duly elected and qualified or until their
respective earlier death, resignation or removal.
Votes FOR
Votes WITHHELD
Broker Non-Votes
Wendy Barnes
2,379,952,868
10,078,860
39,543,093
Ronald E. Bruehlman
2,380,863,641
9,168,087
39,543,093
Gregory Mondre
2,382,474,121
7,557,607
39,543,093
Item 2 — Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting
firm for the fiscal year ending December 31, 2026.
Votes FOR
Votes AGAINST
Votes ABSTAINED
Broker Non-Votes
2,429,055,999
335,716
183,106
0
Item 3 — Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive
officers.
Votes FOR
Votes AGAINST
Votes ABSTAINED
Broker Non-Votes
2,363,913,370
23,702,520
2,415,838
39,543,093
Based on the foregoing votes, the Company’s stockholders (i) elected Wendy Barnes, Ronald E. Bruehlman and
Gregory Mondre as Class III directors; (ii) ratified the appointment of KPMG LLP as the Company’s independent registered
public accounting firm for the fiscal year ending December 31, 2026; and (iii) approved, on an advisory (non-binding) basis,
the compensation of the Company’s named executive officers.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report
to be signed on its behalf by the undersigned hereunto duly authorized.
GOODRX HOLDINGS, INC.
Date:
June 18, 2026
By:
/s/ Christopher McGinnis
Name: Christopher McGinnis
Title: Chief Financial Officer & Treasurer

FAQ

What did GoodRx (GDRX) stockholders approve at the June 16, 2026 annual meeting?

GoodRx stockholders approved all three proposals presented. They elected three Class III directors, ratified KPMG LLP as independent auditor for the 2026 fiscal year, and approved, on an advisory and non-binding basis, the compensation of the company’s named executive officers.

Which directors were elected at GoodRx (GDRX)’s 2026 annual stockholder meeting?

Stockholders elected Wendy Barnes, Ronald E. Bruehlman and Gregory Mondre as Class III directors. Their terms run until the 2029 annual meeting, and they will serve until successors are duly elected and qualified or until earlier death, resignation or removal.

How many GoodRx (GDRX) shares and voting power were represented at the 2026 annual meeting?

The meeting had 89,932,951 Class A shares and 233,964,187 Class B shares represented. This presence accounted for approximately 99.4% of the combined voting power of GoodRx’s Class A and Class B common stock as of the April 20, 2026 record date.

Which auditing firm did GoodRx (GDRX) stockholders ratify for the 2026 fiscal year?

Stockholders ratified the appointment of KPMG LLP as GoodRx’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The ratification vote received 2,429,055,999 votes for, 335,716 against, and 183,106 abstentions, with no broker non-votes recorded.

How did GoodRx (GDRX) stockholders vote on executive compensation in 2026?

On an advisory, non-binding basis, stockholders approved the compensation of GoodRx’s named executive officers. The vote totaled 2,363,913,370 shares for, 23,702,520 against, and 2,415,838 abstentions, with 39,543,093 broker non-votes reported on this say-on-pay proposal.

What voting rights did GoodRx (GDRX) Class A and Class B shares have for the 2026 meeting?

For the 2026 annual meeting, each share of Class A common stock carried one vote, while each share of Class B common stock carried ten votes. These voting rights applied to holders of record as of the April 20, 2026 record date for all proposals.

Filing Exhibits & Attachments

3 documents